Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease

An international consortium published the final results of a key clinical trial of the gene therapy CASGEVY (exagamglogene autotemcel) for the treatment of sick

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Stephana Grupp ,Exagamglogene Autotemcel ,Vertex Pharmaceuticals ,Stephenp Kelly Center ,Gene Therapy Laboratory ,New England Journal ,Section Chief ,Cellular Therapy ,Transplant Section ,Inaugural Director ,Medical Director ,Severe Sickle Cell Disease ,Online April ,